Form 8-K - Current report:
SEC Accession No. 0001140361-23-007944
Filing Date
2023-02-22
Accepted
2023-02-22 11:15:35
Documents
14
Period of Report
2023-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10048570_8k.htm   iXBRL 8-K 29060
2 EXHIBIT 99.1 brhc10048570_ex99-1.htm EX-99.1 388374
6 image0.jpg GRAPHIC 68119
  Complete submission text file 0001140361-23-007944.txt   673641

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20230222.xsd EX-101.SCH 3874
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20230222_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20230222_pre.xml EX-101.PRE 16050
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10048570_8k_htm.xml XML 4072
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 23651171
SIC: 2834 Pharmaceutical Preparations